Eutropics Pharmaceuticals
UEI: VYD9LKBYHHQ3
• CAGE: 4BBT8
Overview
Awardee Type
Parent
Company Description
Eutropics’ PraediCare Dx™ platform provides a biomarker technology for accelerating drug discovery and development.
Name
Eutropics Pharmaceuticals
Website
Headquarters
Cambridge, MA
United States
United States
Most Recent Award
Feb. 4, 2019
Calculating
Federal contract and grant recipient
EUTROPICS PHARMACEUTICALS
(UEI VYD9LKBYHHQ3, CAGE 4BBT8)
is headquartered in Cambridge MA.
The corporation
was founded in August 2005 and
federally registered in
February 2006.
Federal Award Analysis
Eutropics Pharmaceuticals federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
EUTROPICS PHARMACEUTICALS
Division Name
EUTROPICS
Division Number
EUTROPICS
UEI
VYD9LKBYHHQ3
CAGE Code
4BBT8
Primary NAICS
None Reported
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Assistance Awards
Date Founded
Aug. 17, 2005
Initial Registration
Feb. 20, 2006
Last Registration
Dec. 15, 2023
Registration Activation
Dec. 19, 2022
Registration Expiration
Dec. 15, 2023
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
Not Available
Reported NAICS
None Reported
Accepts Credit Cards
No